Literature DB >> 20090527

The genetics of scleroderma (systemic sclerosis).

Sandeep K Agarwal1, John D Reveille.   

Abstract

PURPOSE OF REVIEW: To determine the advances made in the genetics of scleroderma in candidate gene association studies. RECENT
FINDINGS: Over the past 18 months, a number of candidate gene studies using large case-control series in scleroderma have been reported. The studies have identified multiple genes involved in immune regulation including BANK1, C8orf13-BLK, IL-23R, IRF5, STAT4, TBX21, and TNFSF4 as susceptibility genes for the development of SSc. Furthermore, gene-gene interaction studies suggest that IRF5, STAT4, and BANK1 as well as TBX21 and STAT4 interact with regard to scleroderma susceptibility. Many of the genetic variants associated with SSc susceptibility are shared among other autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus.
SUMMARY: Candidate gene association studies have substantially advanced our understanding of the pathogenesis of SSc and demonstrate that SSc is a polygenic, autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20090527     DOI: 10.1097/BOR.0b013e3283367c17

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  19 in total

Review 1.  The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.

Authors:  Yoshihide Asano; Andreea M Bujor; Maria Trojanowska
Journal:  J Dermatol Sci       Date:  2010-07-03       Impact factor: 4.563

Review 2.  Biomarkers in the management of scleroderma: an update.

Authors:  Giuseppina Abignano; Maya Buch; Paul Emery; Francesco Del Galdo
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

3.  Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis.

Authors:  F David Carmona; Ramana Gutala; Carmen P Simeón; Patricia Carreira; Norberto Ortego-Centeno; Esther Vicente-Rabaneda; Francisco J García-Hernández; Paloma García de la Peña; Mónica Fernández-Castro; Lina Martínez-Estupiñán; María Victoria Egurbide; Betty P Tsao; Pravitt Gourh; Sandeep K Agarwal; Shervin Assassi; Maureen D Mayes; Frank C Arnett; Filemon K Tan; Javier Martín
Journal:  Ann Rheum Dis       Date:  2011-09-16       Impact factor: 19.103

4.  Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis.

Authors:  Lorenzo Beretta; Blanca Rueda; Maurizio Marchini; Alessandro Santaniello; Carmen P Simeón; Vicente Fonollosa; Monica Caronni; Raquel Rios-Fernandez; Patricia Carreira; Luis Rodriguez-Rodriguez; Antonia Moreno; Miguel A López-Nevot; Ana Escalera; Maria F González-Escribano; Javier Martin; Raffaella Scorza
Journal:  Rheumatology (Oxford)       Date:  2011-11-15       Impact factor: 7.580

5.  [Genetic analysis in collagen vascular diseases].

Authors:  I Melchers
Journal:  Z Rheumatol       Date:  2011-04       Impact factor: 1.372

6.  Association of BLK (rs13277113, rs2248932) polymorphism with systemic lupus erythematosus: a meta-analysis.

Authors:  Ye Fan; Jin-Hui Tao; Li-Ping Zhang; Lian-Hong Li; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-12-09       Impact factor: 2.316

7.  Antinuclear antibody-negative systemic sclerosis.

Authors:  Gloria A Salazar; Shervin Assassi; Fredrick Wigley; Laura Hummers; John Varga; Monique Hinchcliff; Dinesh Khanna; Elena Schiopu; Kristine Phillips; Daniel E Furst; Virginia Steen; Murray Baron; Marie Hudson; Suzanne S Taillefer; Janet Pope; Niall Jones; Peter Docherty; Nader A Khalidi; David Robinson; Robert W Simms; Richard M Silver; Tracy M Frech; Barri J Fessler; Jerry A Molitor; Marvin J Fritzler; Barbara M Segal; Firas Al-Kassab; Marilyn Perry; Jeremy Yang; Sara Zamanian; John D Reveille; Frank C Arnett; Claudia Pedroza; Maureen D Mayes
Journal:  Semin Arthritis Rheum       Date:  2014-11-28       Impact factor: 5.532

8.  Association of HLA-DRB1*15:02 and DRB5*01:02 allele with the susceptibility to systemic sclerosis in Thai patients.

Authors:  Worawit Louthrenoo; Nuntana Kasitanon; Ramjai Wichainun; Suparaporn Wangkaew; Waraporn Sukitawut; Yuka Ohnogi; Naoko Nakaue; Shoji Kuwata; Fujio Takeuchi
Journal:  Rheumatol Int       Date:  2013-02-13       Impact factor: 2.631

9.  Diffuse Systemic Sclerosis in a Patient with Primary Biliary Cirrhosis and Autoimmune Hepatitis Overlap Syndrome: A Case Report.

Authors:  Hye Sung Han; Ga Ram Ahn; Hyung Joon Kim; Kui Young Park; Kapsok Li; Seong Jun Seo
Journal:  Ann Dermatol       Date:  2019-12-27       Impact factor: 1.444

10.  The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.

Authors:  F David Carmona; Jose-Ezequiel Martin; Lorenzo Beretta; Carmen P Simeón; Patricia E Carreira; José Luis Callejas; Mónica Fernández-Castro; Luis Sáez-Comet; Emma Beltrán; María Teresa Camps; María Victoria Egurbide; Paolo Airó; Raffaella Scorza; Claudio Lunardi; Nicolas Hunzelmann; Gabriela Riemekasten; Torsten Witte; Alexander Kreuter; Jörg H W Distler; Rajan Madhok; Paul Shiels; Jacob M van Laar; Carmen Fonseca; Christopher Denton; Ariane Herrick; Jane Worthington; Annemie J Schuerwegh; Madelon C Vonk; Alexandre E Voskuyl; Timothy R D J Radstake; Javier Martín
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.